Table 1. Cognitive Outcomes for Valproate Subjects Across Human Studies.
| Study | Enrollment Design |
Blinded to AED |
Valproate MonoTx |
Other AED MonoTx |
Significant Outcome |
|---|---|---|---|---|---|
| Adab 2004[10] |
Retrospective | No | N=41 | Carbamazepine Phenytion | WISC-III[17] Verbal IQ |
| Gaily 2004[8] |
Prospective | Yes | N=13 | Carbamazepine | WPPSI-R[18] or WISC- R[19] Verbal IQ |
| Eriksson 2005[6] |
Prospective | Yes | N=21 | Carbamazepine | WISC-III IQ [17] |
| Meador 2009[7] |
Prospective | Yes | N=53 | Carbamazepine Lamotrigine Phenytoin |
DAS IQ [20] and BMDI [21] |
AED = Antiepileptic drug; MonoTx = Prenatal exposure to AED monotherapy; DAS = Differential Abilities Scales [20], a standardized intelligence quotient that measures generalized cognitive ability (GCA), administered to this cohort at 36–45 months; BMDI = Bayley Mental Development Index[21], a standardized behavioral measure of cognitive development, administered to this cohort at 21–34 months; WISC = Wechsler Intelligence Scale for Childen [17, 19]; WPPSI = Wechsler Preschool and Primary Scale of Intelligence [18].